Загрузка...

Why is HIMS being shorted at 45% despite massive growth?

The market narrative surrounding HIMS faces a reality check. Despite reporting profitability in 10 of the last 11 quarters and achieving triple-digit revenue growth across dermatology, weight loss, and mental health sectors, the stock faces an unusual 45% short interest. This disconnect between strong fundamental business performance and aggressive short-selling suggests there is more to the story than standard valuation concerns. Expert quantitative analysis now adds weight to the skepticism regarding whether this short position is truly based on the company's financial health.
#HIMS #StockMarket #Investing #ShortSqueeze #FinancialAnalysis #MarketTrends

Видео Why is HIMS being shorted at 45% despite massive growth? канала Mikele X10 Stocks 2
Яндекс.Метрика
Все заметки Новая заметка Страницу в заметки
Страницу в закладки Мои закладки
На информационно-развлекательном портале SALDA.WS применяются cookie-файлы. Нажимая кнопку Принять, вы подтверждаете свое согласие на их использование.
О CookiesНапомнить позжеПринять